BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29397850)

  • 1. [Efficacy of Recombinant Human Thrombopoietin and Recombinant Human Interleukin 11 for Treatment of Chemotherapy Indu-ced Thrombocytopenia in Acute Myeloid Leukaemia Patients].
    Tang G; Wang XM; Meng JX; Luan CL; Chen JF; Wu YQ; Zhang XN; He ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):234-238. PubMed ID: 29397850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of rhTPO and rhIL-11 on Thrombocytopenia after Chemotherapy in Leukemia].
    Dai JF; Xia RX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):711-717. PubMed ID: 35680794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact on platelet recovery of recombinant human thrombopoietin in severe aplastic anemia patients with allogeneic hematopoietic stem cell transplantation].
    Song Y; Zhou F; Song NX; Liu XM; Yu Z; Xie LN; Song XC; Li X
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):207-211. PubMed ID: 29562465
    [No Abstract]   [Full Text] [Related]  

  • 4. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
    Chen M; Li L; Xia Q; Chen X; Liao Z; Wang C; Shen B; Zhou M; Zhang Q; Zhang Y; Qian L; Yuan X; Wang Z; Xue C; An X; Liu B; Gu K; Hou M; Wang X; Wang W; Li E; Zhong J; Cheng J; Shu Y; Yang N; Wang H; Yang R; Liu T; Deng T; Ma F; Liao W; Qiu W; Chen Y; Chen X; Zhang M; Xu R; Li X; Feng J; Ba Y; Shi Y
    Cancer; 2024 Apr; 130(S8):1524-1538. PubMed ID: 38515388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of rhTPO and rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia in hematological tumors based on real-world data.
    Zhang JJ; Zhao R; Xia F; Li Y; Wang RW; Guan X; Zhu JG; Ma AX
    Ann Palliat Med; 2022 Aug; 11(8):2709-2719. PubMed ID: 36064361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
    Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Recombinant Human Thrombopoietin on Platelet Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma].
    Xie Y; Yan LZ; You T; Shi XL; Yan S; Zhai YY; Shang JJ; Yan Z; You HY; Wang QQ; Wu DP; Fu CC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):505-511. PubMed ID: 38660859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Dai XF; Yu J; Liu L; Wu G
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):623-5. PubMed ID: 19102944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
    van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
    Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of recombinant human thrombopoietin on endotoxin-induced thrombocytopenia in mice].
    Jiang J; Wang B; Yu X; Xu H; Wang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1108-1112. PubMed ID: 31657334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical Analysis of Recombinant Human Thrombopoietin for Treatment of 46 Adult Patients with Newly Diagnosed Primary Immune Thrombocytopenia].
    Wang M; Liu YF; Sun H; Xie XS; Ma J; Gan SL; Dong YJ; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):531-5. PubMed ID: 27151024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018)].
    Consensus Committee of Chemotherapy Induced Thrombocytopenia, Chinese Society of Clinical Oncology
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):714-720. PubMed ID: 30293399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research.
    Gong FM; Liu FY; Ma X; Ma ST; Xiao HT; Jiang G; Qi TT
    Front Pharmacol; 2024; 15():1288964. PubMed ID: 38327986
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
    Xu YH; Chen ZW; Ye XY; Lu S
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: a clinical study].
    Dong F; Ma N; Chang S; Yang H; Gao M; Liu Q; Sun X; Liang M; Sun R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1445-1449. PubMed ID: 33541495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia.
    Wang X; Bi H; Liu L; Liu Y; Yin L; Yao J; Yu J; Tao W; Wei Y; Li Y; Yin L; Mu H; Du Y; Zhou Z
    Platelets; 2023 Dec; 34(1):2271568. PubMed ID: 37941414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.
    Liu X; Bai Y; Wang T; Song Y; Sun F; Xia R; Zhu F; Ma J; Lu Q; Ye X; Zhan X; Li L; Guo X; Cheng S; Li Y; Guo Z; Chen Y; Qian S; Qin L; Zhang Q; Cao S; Yang R
    Platelets; 2023 Dec; 34(1):2157806. PubMed ID: 36597010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic recombinant human thrombopoietin treatment alleviates chemotherapy- induced thrombocytopenia in tumor patients].
    Li Q; Ye M; Xiao W; Zhu J; Zhang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1064-6. PubMed ID: 22820601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
    Liu Y; Jin G; Sun J; Wang X; Guo L
    Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.